MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Gut Microbial Metabolites and Future Risk of Parkinson’s Disease: A Metabolome-wide Association Study

    Y. Zhao, Y. Lai, S. Darweesh, B. Bloem, L. Forsgren, J. Hansen, JM. Huerta, M. Guevara, C. Lill, G. Miller, S. Peters, R. Vermeulen (Utrecht, Netherlands)

    Objective: To prospectively investigate the association between plasma microbial metabolites and Parkinson’s disease (PD) risk within a metabolomics framework. Background: Gut microbiota is altered in…
  • 2024 International Congress

    A Machine Learning Approach for Early Identification of Prodromal Parkinson’s Disease

    A. Vaish (Redmond, USA)

    Objective: The aim of this project is to analyze available data of voice, Tappy keystroke, spiral drawings, and gait sample data involving PD patients and…
  • 2024 International Congress

    First in vivo evidence of the role of the noradrenergic system in olfactory dysfunction in Parkinson’s disease

    C. Laurencin, S. Lancelot, S. Brosse, J. Redouté, I. Mérida, D. Le Bars, N. Costes, S. Thobois, P. Boulinguez, B. Ballanger (lyon, France)

    Objective: To investigate the relationship between in vivo noradrenergic markers and olfactory impairment in patients with Parkinson’s disease (PD). Background: Degeneration of the noradrenergic (NA)…
  • 2024 International Congress

    Dopamine Transporter Imaging as Monitoring Biomarker in Parkinson’s Disease

    V. Dzialas, G. Bischof, K. Möllenhoff, A. Drzezga, T. van Eimeren (Cologne, Germany)

    Objective: To investigate the longitudinal relationship between changes in dopamine transporter single-photon emission computed tomography (DaT SPECT) and changes in motor symptom severity in Parkinson’s…
  • 2024 International Congress

    Data-driven image-based subtyping and staging of neurodegeneration in Parkinson’s disease

    J. Ha, G. Park, JS. Lee, JH. Ahn, W. Kim, JW. Cho, H. Kim, J. Youn (Seoul, Republic of Korea)

    Objective: We aimed to conduct image-based, data-driven classification of Parkinson’s disease (PD) progression using event-based modeling (EBM) and derive neuropathological insights from the results. Background:…
  • 2024 International Congress

    Characterizing levodopa-induced dyskinesias using multimodal neuroimaging, clinical and behavioral measures

    S. Shukla, S. Tinaz, N. Thirugnanasambandam (Mumbai, India)

    Objective: Our objective is to investigate potential differential modulation in motor and executive function networks among patients with LID, and to explore its correlation with…
  • 2024 International Congress

    Clinical Trends and Clinician Perceptions Regarding Asleep and Awake DBS

    Y. Gordeyeva, B. Dalm, L. Almeida, S. de Jesus, A. Fasano, K. Foote, J. Jimenez-Shahed, D. Pathadan, N. Pouratian, J. Rolston, J. Rosenow, D. Safarpour, J. Schwalb, M. Siddiqui, M. Spindler, A. Tsai, J. Wong, L. Metman (Poznan, Poland)

    Objective: To determine trends and perceptions regarding Asleep and Awake Deep Brain Stimulation (DBS) in the USA and abroad. Background: DBS clinical practice continues to…
  • 2024 International Congress

    Deep Brain Stimulation Complications in Parkinson’s Disease Patients: A 15-year Single-Centre Review

    J. Cheong, S. Welch, M. Nasir, R. Matar, H. Low, A. Misbahuddin (London, United Kingdom)

    Objective: This study aims to identify the complications of subthalamic nucleus (STN) deep brain stimulation (DBS) in patients with advanced Parkinson’s disease (PD) to direct…
  • 2024 International Congress

    Clinical and Imaging Changes in Parkinson’s Disease Patients Under Spinal Cord Stimulation: A Double Blinded Analysis

    R. Carra, L. Garcia, J. Menezes, T. Capato, E. Barbosa, K. Duarte, M. Teixeira, R. Cury (Sao Paulo, Brazil)

    Objective: Evaluate clinical and biomarker changes from spinal cord stimulation (SCS) in Parkinsons Disease (PD) under sham controlled randomized evaluation. Background: SCS has been proposed…
  • 2024 International Congress

    Risk Tolerance of Therapeutic Interventions in People with Parkinson’s Disease

    B. Dukes, A. Colombo, K. Patel, D. Shah-Zamora (Winston Salem, USA)

    Objective: To determine the sociodemographic factors of people with Parkinson’s disease (PD) associated with risk tolerance when considering interventions. Background: Gender and racial disparities in…
  • « Previous Page
  • 1
  • …
  • 90
  • 91
  • 92
  • 93
  • 94
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley